Anatomy for Subaortic Stenosis (SubAS) Resection

Fundamental Surgical Map: “Know the neighborhood before you cut.”

Subaortic stenosis (SubAS) most often presents as a discrete fibromuscular ridge or membrane located just beneath the aortic valve, frequently along the aorto–mitral continuity (the LVOT “curtain”). This is a uniquely “high-stakes” zone because the valve hinges, fibrous trigones, membranous septum, and conduction axis converge within a very compact 3D space. Accordingly, the durability of a SubAS operation is determined not only by “how much you remove,” but by how precisely you navigate this crossroads.[1,2] (PubMed)

1) The LVOT “crossroads”: a 3D box you should visualize pre-incision

Think of the SubAS target as a ring-shaped working zone at the cardiac base—your slide captures the essential boundaries:

1. Superior (outlet) boundary — the aortic valve plane
• SubAS tissue is subvalvar, but may be adherent near cusp insertion; careless traction risks cusp trauma and postoperative aortic regurgitation (AR).[8,9] (PubMed)
2. Posterior–left boundary — aorto–mitral continuity / anterior mitral leaflet (AML)
• The LVOT roof is fibrous and continuous with the AML; posterior extension of the membrane is where mitral leaflet/chordal injury can occur, and “peeling” near valve tissue becomes a recurrence-risk marker in several outcome series.[6,8] (PubMed)
3. Right-sided boundary — membranous septum + right fibrous trigone (“the hazard corner”)
• This junctional fibrous area is the orientation anchor and simultaneously the conduction-risk corner (His bundle proximity). Your labeled membranous septum / AV node region is exactly the mental red-zone surgeons must map before myectomy.[7] (PubMed)
4. Anterior–right spatial context — RVOT / pulmonary valve “across the septum”
• Even though resection is usually approached transaortically, the outflow septal geometry helps explain why some patients behave like tunnel narrowing rather than a purely discrete shelf (important for planning the extent/direction of myectomy).[1,2] (PubMed)

2) Why SubAS progresses: anatomy + flow = biology (not just a “membrane”)

SubAS is often described as “acquired” in behavior: LVOT geometry creates abnormal shear/turbulence, which promotes subvalvar tissue proliferation and can recur even after technically successful surgery.[1,3] (PubMed)

Clinical translation: the operation must correct the obstructing tissue and ensure the post-resection LVOT caliber/contour does not perpetuate the same high-shear flow environment.

3) The conduction hazard zone: where a perfect resection becomes a complication

A practical operative rule remains:

The closer the resection approaches the membranous septum/right fibrous trigone region, the higher the conduction risk.

• Large series demonstrate that transient or permanent heart block is a meaningful complication signal of how close the dissection came to the conduction axis; pacemaker implantation is an important “cost” of overly aggressive or misdirected resection.[7] (PubMed)

Surgical micro-strategy (high-yield):

• Identify the membranous septum side early (orientation first, resection second).
• Plan myectomy depth and vector away from the conduction corner.
• Favor sharp, controlled peeling over traction when the membrane is adherent near valve hinges.

4) Indications and timing: thresholds help, but anatomy drives the decision

Across contemporary reviews and pediatric outcome literature, intervention is typically considered when there is progressive obstruction and/or valve injury, recognizing that timing remains debated and patient-specific.[1,2] (PubMed)

Common decision drivers include:

• Rising Doppler gradients (especially rapid progression)
• Aortic regurgitation or cusp injury signals
• LV hypertrophy/symptoms
• High-risk anatomy (short valve-to-membrane distance; tunnel physiology)

5) Operative principles: “complete relief” while respecting the neighborhood

A) The durable goal

Relieve LVOT obstruction circumferentially while preserving:

• Aortic cusps
• AML / aorto–mitral curtain
• Membranous septum–His region

B) Membrane resection ± septal myectomy: why many surgeons add myectomy

Classic surgical data support the concept that membrane resection combined with a well-directed septal myectomy can improve gradients and may reduce recurrence—but only if the resection remains anatomically disciplined.[4] (PubMed)

Key nuance: “Aggressive” is not synonymous with “wide.” It should mean complete removal of the offending substrate + a geometry-correcting myectomy, not indiscriminate depth near the conduction corner.

6) Recurrence and reintervention: what consistently predicts trouble

Multiple cohorts converge on a consistent risk signal set:

• Younger age at repair (biologic tendency + growth-related geometry)
• Higher preoperative LVOT gradient (often ≥60–65 mmHg in risk models)
• Short distance from membrane to aortic valve (≈ <5–6 mm)
• Valve “peeling” requirement (a marker of adhesion/valve involvement)

These predictors are repeatedly identified in pediatric series and prediction models.[5,6,8] (PubMed)

Implication: when these features are present, the follow-up strategy should be explicitly “recurrence-aware,” and the operative plan should emphasize post-resection LVOT geometry (not only removal of visible membrane).

7) Long-term outcomes: excellent survival, meaningful reoperation burden

Modern series show:

• Very good survival, but
• Non-trivial reoperation rates and progression of AR over time—supporting the need for long-horizon surveillance.[7–9] (PubMed)

This is the essential counseling message: SubAS surgery is often effective, but the disease biology can remain active.

8) Imaging-to-OR checklist: echo/CT/MRI → the operative “map”

Before entering the OR, explicitly document:

• Phenotype: discrete membrane vs fibromuscular ridge vs tunnel narrowing[1,2]
• Aortic valve–to–membrane distance: short distances predict recurrence risk[5,6,8]
• Valve status: baseline AR/cusp restriction; jet direction toward cusps[8,9]
• Septal geometry: focal bulge suitable for limited myectomy vs diffuse narrowing
• Orientation landmarks: identify the membranous septum side and planned “safe vectors” (your figure’s labeled anatomy is ideal for this mental rehearsal)

References (PubMed-verified)

[1] Devabhaktuni SR, Chakfeh E, Malik AO, Pengson JA, Rana J, Ahsan CH. Subvalvular aortic stenosis: a review of current literature. Clin Cardiol. 2018;41(1):131-136. (PubMed)

[2] Etnel JRG, Takkenberg JJM, Spaans LG, Bogers AJJC, Helbing WA. Paediatric subvalvular aortic stenosis: a systematic review and meta-analysis of natural history and surgical outcome. Eur J Cardiothorac Surg. 2015;48(2):212-220. (PubMed)

[3] Gewillig M, Daenen W, Dumoulin M, Van der Hauwaert L. Rheologic genesis of discrete subvalvular aortic stenosis: a Doppler echocardiographic study. J Am Coll Cardiol. 1992;19(4):818-824. (PubMed)

[4] Rayburn ST, Netherland DE, Heath BJ. Discrete membranous subaortic stenosis: improved results after resection and myectomy. Ann Thorac Surg. 1997;64(1):105-109. (PubMed)

[5] Geva A, McMahon CJ, Gauvreau K, del Nido PJ, Geva T. Risk factors for reoperation after repair of discrete subaortic stenosis in children. J Am Coll Cardiol. 2007;50(15):1498-1504. (PubMed)

[6] Carlson L, Sileshi B, Chanani N, et al. Preoperative Factors That Predict Recurrence After Repair of Discrete Subaortic Stenosis. Ann Thorac Surg. 2021;111(5):1613-1619. (PubMed)

[7] Jou CJ, LaDisa JF Jr, Smaha LA, et al. Long-term Outcome and Risk of Heart Block After Surgical Treatment of Subaortic Stenosis. World J Pediatr Congenit Heart Surg. 2010;1(1):15-19. (PubMed)

[8] Pickard SS, Geva A, Gauvreau K, del Nido PJ, Geva T. Long-term outcomes and risk factors for aortic regurgitation after discrete subvalvular aortic stenosis resection in children. Heart. 2015;101(19):1547-1553. (PubMed)

[9] Donald JS, Bove EL, Devaney EJ, et al. Outcomes of Subaortic Obstruction Resection in Children. Heart Lung Circ. 2017;26(2):179-186. (PubMed)

[10] Uysal F, Bostan OM, Signak IS, Semizel E, Cil E. Evaluation of subvalvular aortic stenosis in children: a 16-year single-center experience. Pediatr Cardiol. 2013;34(6):1409-1414. (PubMed)